Yield10 Bioscience Inc reports results for the quarter ended in June - Earnings Summary

Yield10 Bioscience

11/08/2021 22:01

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly adjusted
loss of 64 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 54 cents per share.
* Revenue fell 21.3% to $174.00 thousand from a year ago; 
analysts expected $199.00 thousand. 
* Yield10 Bioscience Inc's reported EPS for the quarter was a
loss of 64 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Yield10 Bioscience Inc shares had fallen by 14.8% this
quarter and gained 25.8% so far this year.
* The company reported a quarterly loss of $3.09 million.
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated